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Abstract
After host entry through mucosal surfaces, HIV-1 disseminates to lymphoid tissues to establish a 
generalized infection of the immune system. The mechanisms by which this virus spreads among 
permissive target cells locally during early stages of transmission, and systemically during 
subsequent dissemination are not known1. In vitro studies suggest that formation of virological 
synapses (VSs) during stable contacts between infected and uninfected T cells greatly increases 
the efficiency of viral transfer2. It is unclear, however, if T cell contacts are sufficiently stable in 
vivo to allow for functional synapse formation under the conditions of perpetual cell motility in 
epithelial3 and lymphoid tissues4. Here, using multiphoton intravital microscopy (MP-IVM), we 
examined the dynamic behavior of HIV-infected T cells in lymph nodes (LNs) of humanized 
mice. We found that most productively infected T cells migrated robustly, resulting in their even 
distribution throughout the LN cortex. A subset of infected cells formed multinucleated syncytia 
through HIV envelope (Env)-dependent cell fusion. Both uncoordinated motility of syncytia as 
well as adhesion to CD4+ LN cells led to the formation of long membrane tethers, increasing cell 
lengths to up to 10 times that of migrating uninfected T cells. Blocking the egress of migratory T 
cells from LNs into efferent lymph, and thus interrupting T cell recirculation, limited HIV 
dissemination and strongly reduced plasma viremia. Thus, we have found that HIV-infected T 
cells are motile, form syncytia, and establish tethering interactions that may facilitate cell-to-cell 
transmission through VSs. While their migration in LNs spreads infection locally, T cell 
recirculation through tissues is important for efficient systemic viral spread, suggesting new 
molecular targets to antagonize HIV infection.
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In HIV infection, lymph nodes are important sites of viral replication, where the high local 
density of CD4+ T cells and other target cells may favor cell contact-mediated viral spread. 
Since infection of BLT (Bone marrow/Liver/Thymus) humanized mice5 replicates many 
hallmarks of infection in humans6–8, we utilized this small animal model (Supplementary 
Fig. 1a) and intravital microscopy to investigate the dynamic behavior of HIV-infected T 
cells in the stromal environment of LNs.
We first sought to validate this mouse model for studying the effects of HIV infection on T 
cell migration. The presence of both naïve and memory human CD4+ and CD8+ T cells in 
secondary lymphoid organs (SLOs) of BLT mice demonstrates their general capacity to 
home to these sites (Fig. 1a). To determine the efficiency of this trafficking process we 
infused BLT mice with mixtures of isogenic CD4+ human T cells and murine CD4+ T cells 
from OT-II TCR transgenic mice. Over the course of 18 hours, human T cells were half as 
efficient as murine cells at entering peripheral LNs, while their accumulation in mesenteric 
LNs was equivalent (Fig. 1b). Thus, the interspecies molecular interactions between 
selectins, chemokine receptors, and integrins on human T cells with their ligands expressed 
on murine LN high endothelial venules9 are collectively functional, albeit at a slightly 
reduced level.
Upon entering LNs, T cell migration is guided by their sensing of chemokines10 and 
interactions with the paracortical fibroblastic reticulum11, which is well preserved in BLT 
mice (Supplementary Fig. 1b). We compared the migration of human and murine T cells in 
BLT LNs by MP-IVM. Intravenously infused human and murine cells distributed similarly 
in the LN cortex, were indistinguishable in various aspects of motility (Fig. 1c–e, 
Supplementary Fig. 1c–e and Video 1), and in this regard each resembled murine T cells in 
fully murine LNs4. We concluded that human T cell homing to LNs was efficient and their 
migration within LNs of BLT mice was, using mouse T cells as reference, normal, allowing 
us to study the impact of HIV infection on this basic process.
In order to seed LNs with HIV we injected BLT mice in the footpad with GFP-expressing, 
CCR5-using HIV (called ‘HIV-GFP’ here), which we derived by replacing the V3 loop 
region of env in the originally CXCR4-tropic NL4-3-IRES-GFP12 with that of HIV BaL 
(Supplementary Fig. 2a, b). Subcutaneous infection reliably produced high levels of plasma 
viremia (Fig. 2a) and systemic infection (Supplementary Fig. 2c). However, between two 
and six days after footpad infection, we detected GFP+ cells only in the ipsilateral popliteal, 
but not remote LNs, indicating that the infection was initially contained in the primary 
draining LNs (Fig. 2b, Supplementary Fig. 2e). The vast majority of these infected cells 
were resting (SSClow), antigen-experienced (CD45RO+) T cells with variable expression of 
CCR7. By day 2 some loss of CD4 cell surface expression was apparent13, but this was 
much more pronounced at day 6, when cells had also downregulated MHC I. 
(Supplementary Fig. 2e).
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To investigate the localization of HIV-infected T cells in LNs early after footpad infection, 
we analyzed draining LNs by MP-IVM two days after virus inoculation. At this time, GFP+ 
cells were evenly distributed up to several hundred μm away from the subcapsular sinus 
(SCS), implying that lymph-borne HIV arriving in the LN SCS has efficient means of 
infiltrating the LN cortex (Fig. 2c). In time-lapse recordings it became apparent that GFP-
expressing LN cells migrated at average 2D velocities of ~7 μm/min and were thus robustly 
motile, suggesting that their motility facilitated the local dissemination of HIV infection in 
LNs (Fig. 2d–f, Supplementary Video 2). Since the majority of infected T cells in early SIV-
infection of macaques are resting memory T cells14, and the majority of infected LN cells in 
our BLT mouse model resembled antigen-experienced T cells (Fig. 2b), we compared their 
motility to that of in vitro-generated, GFP-expressing, central memory-like CD4+ human T 
cells (“Tcm”) that express CD62L and CCR7 and migrate to LNs after adoptive transfer 
(Supplementary Fig. 3a–c). Compared to this reference population, the motility of HIV-
infected LN cells was reduced (Fig. 2e, f, Supplementary Fig. 3d, e, and Videos 2, 3), which 
may reflect the ability of HIV to interfere with cytoskeletal processes involved in cell 
migration15, 16.
While most infected LN cells resembled antigen-experienced T cell in terms of motility as 
well as size and shape, a subpopulation (10–20%) of cells stood out by their unusually 
elongated, thin, and sometimes branched trailing edges. These cells reached average skeletal 
lengths of at times more than 100 μm, while Tcm rarely exceeded 20 μm (Fig. 2g, h, 
Supplementary Videos 2–4). When we tracked skeletal lengths in individual cells along with 
their motility, we noted that some of the elongated cells continued to be motile (Fig. 2i). 
Similar results were obtained with SF162R317, a GFP-expressing strain derived from the 
primary R5-tropic clone SF162 (Supplementary Fig. 4 and Video 5).
Since it was possible that our flow cytometry analysis failed to detect these elongated cells 
(Fig. 2b), and that these were in fact not T cells, we wanted to determine unambiguously 
whether HIV-infected T cells could acquire such unusual morphological characteristics in 
vivo. Therefore, we adopted a co-culture method18 to efficiently infect Tcm with HIV-GFP 
in vitro (Fig. 3a), and transferred these cells into footpads of BLT mice, from where they 
migrated to draining popLNs. Recipient BLT mice were pre-treated with a cocktail of 
antiviral drugs6 to prevent infection of any host cells. Under these conditions, where the T 
cell identity of GFP+ cells in popLNs was known, we observed the same overall reduction in 
motility as well as a sub-population of abnormally elongated cells at a similar frequency as 
after in situ infection (Fig. 3b–d and Supplementary Video 6). Co-injection of uninfected 
Tcm also confirmed that these and HIV-infected T cells localized to the same regions of the 
LN and that decreased motility of HIV-infected cells did not result from their sequestration 
into a particular microenvironment (Supplementary Fig. 5 and Video 6).
The elongated morphology could result from infection of a T cell population that has an 
intrinsic propensity to adopt such shapes. Alternatively, HIV proteins might actively induce 
this phenotype. To distinguish between these two possibilities, we generated a CCR5-using, 
HIV-derived lentiviral vector that expresses GFP, but no HIV proteins in infected cells (Fig. 
3e). Two days after footpad injection, a similar number of GFP+ cells were observed in 
draining LNs as after infection with HIV-GFP. However, these cells did not exhibit 
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elongated shapes. They also migrated faster than HIV-GFP-infected LN cells and at similar 
speeds as Tcm (Fig. 3f–h and Supplementary Video 7), further supporting that HIV induces 
migratory deceleration of infected cells. Thus, one or several HIV proteins induce the 
abnormal shapes and decreased motility of HIV-infected T cells.
During HIV assembly, which in migrating, polarized T cells takes place at the uropod19, the 
HIV Env glycoprotein is exposed on the cell surface and can trigger the formation of 
intercellular adhesive contacts with CD4-expressing cells in vitro20–23. In the LN 
environment, where T cells are highly motile, such adhesive interactions could lead to 
abnormal uropod elongation through tethering of infected T cells to uninfected CD4+ LN 
cells. Supporting this scenario, we consistently observed stationary behavior of the trailing 
edges of migrating T cells, often followed by their rapid retraction, perhaps reflecting 
sudden release of tethered uropods (Supplementary Video 8). Alternatively, cellular 
elongations could also result from the formation of multinucleated syncytia, which also 
depends on the function of Env24. In order to test if either uropod tethering or syncytia 
formation are involved in the elongation of HIV-infected T cells we generated HIV-GFP 
ΔEnv, where large parts of Env, including the CD4-binding region, are not expressed 
(Supplementary Fig. 6a). When trans-complemented with an exogenous R5 HIV envelope, 
the virus was as infectious as HIV-GFP, but no secondary infections occurred, as expected, 
since infected cells expressed no functional Env (Supplementary Fig. 6b–d). Strikingly, the 
elongated phenotype of infected LN cells was completely lost in absence of functional Env 
(Fig. 4a–c and Supplementary Video 9). However, cells infected with HIV-GFP ΔEnv still 
migrated at reduced speeds (Fig. 4b, c), suggesting that HIV factors other than Env were 
largely responsible for decreased T cell motility. Cell elongation did not result from artificial 
interactions of Env with murine adhesion or extracellular matrix proteins, since it was not 
observed in HIV-infected Tcm migrating in LNs of non-humanized mice (Fig. 4d and 
Supplementary Fig. 7). To test whether interactions of Env specifically with CD4, or with 
other human ligands, such as the α4β7-integrin25, are involved in tethering, we mutated 
HIV-GFP to exchange a single critical amino acid in Env (D368R in the HBX2 consensus 
sequence) to abrogate CD4-binding26 (Supplementary Fig. 8). Cells infected with HIV-GFP 
D368R showed the same loss of cell elongation as observed after deletion of Env (Fig. 4d).
To examine if some of the highly elongated T cells are part of multinucleated syncytia, we 
analyzed infected BLT LNs by histology. However, while we did find GFP-expressing cells 
with multiple nuclei (not shown), we were unable to visualize the elaborate tethers observed 
by MP-IVM in thick tissue sections, which may explain in part why these presumably highly 
labile structures have not been observed in human histological tissue samples. Therefore, we 
generated HIV-nGFP, in which GFP is targeted to cell nuclei through addition of a nuclear 
localization signal (Supplementary Fig. 9). When we infected BLT mice with this strain, we 
observed by MP-IVM that the vast majority of elongated LN cells were multinucleated 
syncytia that, given the involvement of Env, most likely developed through cell fusion (Fig. 
4e, f). These syncytia frequently migrated with their tightly clustered nuclei moving in a 
coordinated fashion, but intermittently dispersed so that individual nuclei moved in different 
directions, yet remained connected by long membrane tethers (Supplementary Video 10). 
However, both fused and unfused cells also formed free-ending tethers, indicating that those 
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were caused by adhesive interactions with non-visualized CD4+ cells (Supplementary Video 
11). While similar membrane tethers, such as nanotubes, can also form between T cells in 
vitro in the absence of viral infection27, Env proteins of HIV and other retroviruses have 
been shown to facilitate their formation23, 28. Adhesive tethers may promote cell-to-cell 
viral transfer through VSs, or may reflect the initiation of cell fusion, or both.
Movement of free HIV virions within and between tissues is likely restricted by the limits of 
diffusion, by anatomical barriers, and by soluble immune factors, such as complement and 
natural antibody2. Allowing infected T cells to retain robust motility and to serve as 
migratory vehicles might therefore be a viral strategy for efficient local and systemic 
dissemination. If indeed long-range transport of HIV to distant tissues relies on the 
trafficking of infected cells during physiological T cell recirculation, then interfering with 
lymphocyte trafficking should limit systemic viral dissemination and reduce plasma viremia. 
To block T cell egress from LNs into efferent lymph vessels we treated BLT mice with the 
functional S1P receptor antagonist FTY720 (Fingolimod), which caused profound 
lymphopenia (Supplementary Fig. 10a).
Strikingly, in mice that received FTY720 starting at the time of infection with HIV-GFP, 
viral RNA in peripheral blood remained within or only slightly above background range 
(Fig. 4g), while the drug did not show antiviral activity in cell culture (Supplementary Fig. 
10b). This result was confirmed with another R5-tropic strain, SF162R3 17 (Fig. 4h). Two 
months after infection, viral RNA was strongly reduced, yet not absent from remote 
lymphoid tissues of treated animals (Supplementary Fig. 10c), suggesting that FTY720 in 
the longer term did not fully prevent, but only limited dissemination within the lymphoid 
system. Accordingly, development of viremia after withdrawal of FTY720 after 8 weeks of 
treatment indicated that the release of T cells from lymphoid tissues rapidly initiated 
efficient systemic viral replication (Fig. 4h). Interestingly, we also observed a reduction in 
viral load in the draining LN in long-term treated animals (Supplementary Fig. 10c). This 
may reflect local depletion of HIV T cell targets, but could also indicate that FTY720 
treatment reduces viral replication through a general perturbation of T cell homeostasis or 
through delayed, direct antiviral activity, independently of its effect on the trafficking of 
HIV-infected T cells. However, FTY720 did not affect viremia in mice with pre-established 
infection (Fig. 4i), similar to what was observed in SHIV infection of macaques29. While we 
cannot rule out other direct or indirect effects of FTY720 on viral replication, the 
observation that HIV infection is limited and high-level viraemia prevented by interfering 
with T-cell recirculation before, but not after systemic viral dissemination, suggests an 
important role for the trafficking of infected, migratory T cells in the efficient transport of 
HIV from draining to remote lymphoid tissues.
In summary, we find that HIV induces a partial reduction in the motility of infected T cells, 
as well as their tethering to and fusion with CD4+ immune cells in LNs. This may reflect the 
need for HIV to tune T cell migratory and interactive behavior in order to meet two 
opposing requirements: The use of motile cells as vehicles to disseminate within and 
between tissues, which inherently involves short-lived cell contacts; and the formation of 
VSs and, possibly, syncytia, for cell-to-cell spread, which likely requires longer-lasting cell 
contacts. Reduced motility of infected T cells might favor the formation and maintenance of 
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tethering contacts with potential HIV target cells, while still allowing for efficient trafficking 
to distant tissues.
METHODS SUMMARY
BLT humanized mice
Sublethally irradiated, female NOD/SCID mice were transplanted under the kidney capsule 
with 1mm3 fragments of human fetal liver and thymus, and injected i.v. with 1–5 × 105 
purified CD34+ human fetal liver cells. After 18–20 weeks, healthy mice with >50% human 
lymphoid reconstitution in peripheral blood were used for experiments within 6 weeks. In 
experiments that did not require popliteal LNs, NOD/SCID x γc−/− (NSG) mice were used 
as graft recipients.
HIV reporter strains
The CCR5-using, GFP-expressing virus NL4-3 IRES-GFP R5 (‘HIV-GFP’) was constructed 
from pBR-NL4-3-IRES-GFP-nef+12 by replacing the V3 loop region of env with the 
corresponding sequence from the R5 clone BaL. HIV-GFP ΔEnv and HIV-GFP D368R 
were generated by site-directed mutagenesis. To produce infectious HIV-GFP ΔEnv and 
HIV-GFP D368R, the BaL Env was trans-complemented using a helper plasmid during 
virus production. HIV-nGFP was generated by inserting the SV40 nuclear localization 
sequence N-terminal of GFP in HIV-GFP. The lentiviral vector pHAGE-CMV-GFP was 
packaged with the R5 Env and standard helper plasmids to produce the CCR5-using ‘R5 
LV-GFP’, which expresses no HIV proteins in infected cells.
MP-IVM of HIV-infected cells in lymph nodes
For in situ-infection of LN cells, BLT mice were injected into the footpad with 0.5 – 1.5 × 
105 infectious units of recombinant HIV or R5 LV-GFP. 48 hours later, the draining popLNs 
were imaged by MP-IVM, as described4. Alternatively, HIV-GFP-infected Tcm were 
injected into the footpads of BLT mice pretreated with antiretroviral drugs, and imaged by 
MP-IVM 12 hours later.
METHODS
BLT humanized mice
Female NOD/SCID (NS) and NOD/SCID x γc−/− (NSG) mice were purchased from Jackson 
Laboratories and reconstituted at age 6–8 weeks with human immune systems as previously 
described30. Briefly, mice were conditioned with sublethal (2 Gy) whole-body irradiation 
and transplanted with 1 mm3 fragments of human fetal thymus and liver (17 to 19 weeks of 
gestational age, from Advanced Bioscience Resources) under the kidney capsule. CD34+ 
cells were isolated from human fetal liver using anti-CD34 microbeads (Miltenyi Biotec) 
and injected intravenously (1 – 5 × 104 cells/mouse) within 6 hours of surgery to create 
“BLT” (Bone marrow, Liver and Thymus) mice. Mice were monitored for human 
hematopoietic reconstitution at 14 and 18 weeks post-transplantation. High lymphoid 
reconstitution in peripheral blood (>25% lymphocytes in PBL, >50% human lymphocytes, 
>40% T cells among lymphocytes) correlated with optimal lymph node reconstitution 
Murooka et al. Page 6
Nature. Author manuscript; available in PMC 2013 April 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
suitable for intravital imaging (typically at 18–20 weeks). NS mice were used for all 
experiments involving footpad injection of HIV or cells and analysis (e.g. by MP-IVM) of 
draining popliteal LNs. NSG mice, which lack popliteal, but possess cervical LNs, were 
used for long-term experiments involving FTY720 treatment.
OT-II TCR transgenic mice were obtained from Jackson Laboratories and bred in house. All 
experiments were performed in accordance to the rules and regulations of the Center of 
Comparative Medicine (CCM) and approved by the MGH Institutional Animal Care and 
Use Committee (IACUC) and the Harvard Medical Area Standing Committee on Animals.
Plasmids and virus production
The proviral plasmid pBR-NL43-IRES-EGFP-nef+ (pIeG-nef+)31 was obtained from the 
NIH AIDS Research & Reference Reagent Program (ARRRP, Catalog #11349). The V3 
loop of env was modified to resemble that of HIV BaL and confer R5-tropism, as previously 
described32. Briefly, a commercial kit (Stratagene) and primers 5′-
cccaacaacaatacaagaaaaagtatacatataggaccaggcagagcattatat 
acaacaggagaaataataggagatataagacaagcacattgtaacattag-3′ and 5′-ctaatgttacaatgtgcttgtc 
ttatatctcctattatttctcctgttgtatataatgctctgcctggtcctatatgtatactttttcttgtattgttgttggg-3′ were used 
according to the manufacturer’s protocol to mutagenize pIeG-nef+ and obtain pIeG-nef+ R5. 
The non-GFP-expressing parental plasmid, pNL4-3, was similarly mutagenized to obtain 
pNL4-3 R5. Infectious virus generated form pIeG-nef+ R5 and pNL4-3 R5 are called ‘HIV-
GFP’ and ‘HIV’ for short.
The pSVIIIexE7-ADA env-expressing vector (kindly provided by Dr. J. Sodroski) was 
modified by restriction cloning to express env from pIeG-nef+ R5 using KpnI and BamHI 
restriction sites to obtain pSVIIIexE7-BaL.
To construct an env-deleted reporter construct, pIeG-nef+ R5 was digested with PsiI 
(nucleotide 6865 and 7599) and re-ligated. The resulting frameshift mutation introduced a 
pre-mature stop codon while the RRE remained intact. The new plasmid pIeG-nef+ Δenv 
was packaged with pSVIIIexE7-BaL to obtain HIV-GFP ΔEnv.
To construct the CD4-binding-deficient reporter virus HIV-GFP D368R, site-directed 
mutagenesis of pIeG-nef+ R5 was performed using primers 5′-
gcaatcctcaggagggcgcccagaaattgtaacg-3′ and 5′-cgttacaatttctgggcgccctcctgaggattgc-3′ 
(Stratagene). Successful mutagenesis was confirmed by DNA sequencing. HIV-GFP D368R 
was packaged with pSVIIIexE7-BaL to obtain single-round infectious viral supernatant.
The lentiviral vector construct pHAGE-CMV-GFP is a modification of a construct originally 
developed in the laboratory of Dr. Richard C. Mulligan at Harvard Medical School33. 
pHAGE-CMV-GFP was packaged with standard helper plasmids and pSVIIIexE7-BaL to 
obtain the non-replicating, R5-using vector R5 LV-GFP. To construct the vector pHAGE-
NLS-Cerulean, first GFP was replaced in pHAGE-CMV-GFP with Cerulean using 
restriction enzyme sites NcoI and XmaI to obtain pHAGE-CMV-Cerulean. Then, the 
complementary primers 5′-agccccatggctccaaaaaagaagagaaaggtaggcgccatggct-3′ and 5′-
agccatggcgcctacctttctcttcttttttggagccatgggct-3′ were annealed, digested with NcoI and 
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inserted into pHAGE-CMV-Cerulean, placing the NLS peptide of SV40 immediately 
upstream of GFP. The same cloning strategy was used to construct HIV-nGFP from HIV-
GFP.
Dr. Amanda Brown at Johns Hopkins University School of Medicine kindly provided 
pSF162R3.
All HIV and lentiviral stocks were produced by transfecting HEK293T cells using 
Lipofectamine 2000 (Invitrogen). Viral supernatants were clarified through a 0.22μm filter 
and centrifuged at 90,000 × g for 2 hours using an SW28Ti rotor (Beckman Coulter) over a 
20% sucrose cushion. Viral stocks were titrated using MAGI.CCR5 cells and expressed as 
bfu/mL (blue focus units/mL) as described previously34.
Cells
Human and murine CD4+ T cells were purified from uninfected BLT and OT-II mice, 
respectively, by negative immuno-magnetic selection (Miltenyl Biotec), and labeled with 2 
μM Celltracker green (CMFDA) or 10 μM Celltracker blue (CMAC, both from Invitrogen) 
before adoptive transfer into BLT mice (see below).
Human CD4+ central memory-like T cells (Tcm) were generated as described previously 
with slight modifications35. Briefly, CD4+ T cells were isolated from spleen and LNs of 
BLT mice by positive immuno-magnetic selection using CD4 microbeads (Miltenyi Biotec) 
to purities consistently above 95%. Cells were activated by adding Dynabeads coated with 
anti-human CD3ε/CD28 antibody (3:1 bead:cell ratio, Invitrogen) for 2 days in RPMI 1640 
supplemented with 10% FCS (Atlanta Biologicals), 2 mM L-glutamine (Gibco), 1mM 
sodium pyruvate and 10mM HEPES (Mediatech). After 2 days, cells were washed and 
cultured for another 6–8 days in medium containing 50 IU/mL human rIL-2 (R&D 
Systems), keeping cell density close to 5 × 105 cells/mL. Cells were used for all experiments 
between days 8 and 10.
To infect Tcm with HIV-GFP with high efficiency, we used a modified co-culture method36. 
Briefly, 2 × 106 MAGI.CCR5 cells were transfected with 10μg of pIeG-nef+ R5 and 24 
hours later T cells were added to the confluent layer of virus-producing cells. Two days 
later, T cells were collected by Ficoll gradient centrifugation and washed three times before 
injection into BLT mice. Since with this approach we could only generate a limiting number 
of HIV-infected Tcm, we injected these into footpads for initially selective and efficient 
delivery to draining LNs,37 since upon i.v. injection cells distributed to all secondary 
lymphoid tissue and accumulated in only smaller numbers in the popliteal LN under study. 
In some studies, HIV-infected Tcm were injected into the footpad of DHLMP2a mice38 
depleted of NK cells through daily i.p. injections of 50μL anti-asialo GM1 antibody (Wako 
Chemicals Inc.) for 2 days.
To generate Tcm that were not infected with HIV-GFP, but expressed GFP for visualization 
by MP-IVM and comparison to HIV-GFP-infected cells, we transduced human T cells with 
VSV-G pseudotyped pHAGE-CMV-GFP on day 2 after activation. In some experiments, 
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uninfected Tcm were stained for 15 min at 37 C with 10 μM CellTracker Orange (CMTMR, 
Invitrogen) before footpad or i.v. injection into BLT mice.
MAGI.CCR5 (Cat. #3522), U87.CD4 (Cat. #4031), U87.CD4.CCR5 (Cat. #4035), 
U87.CD4.CXCR4 (Cat. #4036) cells were all obtained from the ARRRP.
T cell homing studies
Isogenic human and murine OT-II CD4+ T cells were purified, differentially labeled with 
celltracker dyes, and injected i.v. into BLT mice. 18 hours later, flow cytometry was used to 
determine homing ratios based on the relative frequencies of human and mouse T cells 
injected and recovered in various tissues.
HIV infection of BLT mice
For analyses of HIV infection in popliteal LNs, BLT mice were injected into footpads with 5 
× 104 – 1.5 × 105 infectious units of various HIV strains.
For longer-term studies on the effects of FTY720 treatment on the course of infection, 4 × 
104 infectious units of HIV-GFP were injected into the cheek skin of NSG-derived BLT 
mice, which is drained by cervical LNs.
Plasma viremia
Mice were bled from the superficial temporal vein at indicated times and sera stored at 
−80°C. Viral RNA was isolated from 20–70 μL of plasma using the QIAamp viral RNA kit 
(Qiagen), reverse transcribed, and cDNA amplified by qPCR using SYBR green (Qiagen) 
on the Lightcycler 480-II (Roche). Plasma from uninfected BLT mice was used to determine 
the RT-PCR background signal, which was consistently higher than the background signal 
obtained with water.
Quantitation of tissue viral load
Mice were sacrificed at the specified days and lymph nodes and spleen were removed and 
stored in 200μL of RNAlater solution overnight (Ambion). Single-cell suspensions from 
tissues were obtained using the gentle MACS dissociator (Miltenyi Biotec) and RNA was 
extracted using a commercial kit (Qiagen). Quantification of viral RNA was performed as 
described above. Viral loads were normalized to total tissue RNA.
Pharmacological treatments
1 mg/kg BW FTY720 or vehicle was injected i.p every other day starting 1 hour before HIV 
infection of BLT mice to block T cell egress from LNs.39
100 mg/kg emtricitabine (FTC) and 150 mg/kg tenofovir disoproxil fumarate (TDF) were 
i.p. injected daily starting 2 days before footpad injection of HIV-infected Tcm to prevent 
infection of recipient BLT mice.
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Intravital multiphoton microscopy and image analysis
BLT mice were anaesthetized and the popLNs microsurgically exposed for MP-IVM as 
previously described40. Imaging depth was typically 80–200 μm below the LN capsule. For 
multiphoton excitation and second harmonic generation, a MaiTai Ti:sapphire laser 
(Newport/Spectra-Physics) was tuned to between 830 and 920 nm for optimized excitation 
of the fluorescent probes used. For four-dimensional recordings of cell migration, stacks of 
11 optical sections (512 × 512 pixels) with 4–5 μm z-spacing were acquired every 15 or 24 
seconds to provide imaging volumes of 40 μm in depth. Emitted light and second harmonic 
signals were detected through 455/50 nm, 525/50 nm, 590/50 nm, and 665/65 band-pass 
filters with non-descanned detectors.
Data sets were transformed in Imaris 7.3.1 (Bitplane) to generate maximum intensity 
projections (MIPs) for export as Quicktime movies. Since automated 3D-tracking of cell 
migration through Imaris did not perform well on the complex shapes of elongated HIV-
infected cells, we used automated or manual 2D-tracking of cell centroids for all motility 
analyses, which yielded slightly lower velocity measurements than 3D-tracking. 2D-cell 
lengths were measured in ImageJ as the longest path connecting front and end of 
unbranched cells or as the sum of path lengths of all branches of individual branched cells 
(“cell skeletal length”). Either instantaneous (frame-by-frame) cell lengths or average cell 
lengths for individual cell tracks are provided. Cell step and track parameters were further 
analyzed in Matlab (Mathworks).
All time-lapse sequences are accelerated 360x over real-time for display as Quicktime 
movies.
Flow cytometry
Phenotypic characterization of T cells was performed on an LSRII (Becton Dickinson), 
using FlowJo software (Tree Star) for analysis. Spleen and LNs were minced with fine 
forceps and passed through a 40 μm mesh to obtain single cell suspensions. Cells were 
washed, counted and stained with a panel of directly conjugated anti-human mAbs: CD3-
APC/Cy7 (HIT3a), CD4-PE/Cy7 (OKT4), CCR7-APC (TG8), CD8-PerCP (RPA-T8), 
CD45RA-PE (HI100), CD45RO-PE (UCHL1), MHC-I-PerCP (W6/32), CCR5-PE (HEK/
1/85a) and CD62L-Alexa488 (DREG-56) (Biolegend).
HIV-infected cells were fixed with 2% PFA after staining before analysis.
Immunohistochemistry
Frozen sections of BLT and C57BL/6 LNs previously fixed in paraformaldehyde were 
processed for histological analysis using standard techniques. Briefly, 20 μm frozen sections 
were permeabilized with Triton X-100, blocked with BSA and anti-CD16/32, and stained 
with polyclonal anti-desmin rabbit IgG (ab15200; abcam) and either mouse anti-human CD4 
mouse IgG1 (clone RPA-T4, Biolegend) or FITC-anti-murine CD4 rat IgG2b (clone GK1.5, 
Biolegend) antibodies. Alexa Fluor 555-anti-rabbit IgG (A31572, Invitrogen) and FITC-anti 
mouse IgG (ab97022, Abcam) were used as secondary antibodies. Stained sections were 
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embedded in VectaShield Hard set (Vector H-1400) and analyzed by multiphoton 
microscopy.
Statistical analysis
Unpaired Student’s t-test and Mann-Whitney U test were used for comparisons of data sets 
with normal or non-normal distribution, respectively, using Prism 5 (GraphPad). For the 
homing studies, one-sample t test was used for comparison to a hypothetical value of 1, 
corresponding to identical homing efficiency. When p-values were smaller than 0.05, 
differences were considered as significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1. Human T cell migration in lymph nodes of BLT mice
a. Human CD4+T cells with naïve (CD45RA+ CCR7+), central memory (CD45RA−, 
CCR7+) and effector memory (CD45RA−, CCR7−) phenotype are represented in lymphoid 
organs and peripheral blood of BLT mice. Relative frequencies in blood are similar to 
humans. Plots are gated on hCD4+, hCD3+ cells. b. Homing of human and murine CD4+ T 
cells into lymphoid tissues (pLN=peripheral, mLN=mesenteric LNs). Data pooled from 
three independent experiments. Values are means±s.e.m. c. Multiphoton intravital 
micrograph of a BLT popliteal LN 24 hours after adoptive transfer of human (green) and 
murine (red) T cells. Graph on the right shows migratory tracks of each population during a 
30-minute recording. d, e. Mean 2D-track velocities (d) and arrest coefficients (e) of murine 
and human T cells in BLT LNs. Lines and numbers indicate medians. Data pooled from 
three recordings/two independent experiments.
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FIGURE 2. In vivo dynamics and phenotype of HIV-infected LN cells
a. Footpad injection of BLT mice with HIV-GFP produces robust and sustained viremia. 
‘HIV’ is identical to HIV-GFP but lacks an IRES-GFP cassette. Similar results as shown 
here for 5 mice were obtained with other routes of infection (Supplementary Fig. 2d). 
Dashed line and grey-shaded area indicate mean and 95% confidence interval of background 
signals obtained from plasma of uninfected mice. b. Draining and non-draining LN cells two 
days after footpad infection with HIV-GFP. Grey dot plots and histograms show 
GFP−SSClow LN cells. rem. LN: remote LNs. c. An intravital micrograph recorded from a 
popLN two days after footpad infection with HIV-GFP. d. Migratory tracks of GFP+ LN 
cells during a 30-minute recording. e, f. Mean 2D-track velocities (e) and arrest coefficients 
(f) of HIV+ LN cells compared to uninfected, GFP-expressing Tcm, recorded in LNs of 
uninfected BLT mice. Lines and numbers indicate medians. Data on HIV-infected LN cells 
and Tcm are representative of four and two independent experiments, resp. g. MP-IVM 
time-lapse recordings of an HIV-infected LN cell (top) and an uninfected Tcm (bottom) in 
BLT LNs. Arrows indicate leading and trailing edge of the infected cell. Elapsed time in 
min:sec. h. Instantaneous cell skeletal length of HIV-infected LN cells and Tcm from 
recordings as shown in (g). Lines indicate medians. Percentages indicate events>30 μm, 
highlighted by dashed blue box. i. Representative traces of infected LN cells and Tcm 
showing instantaneous cell skeletal length (color-coded) and instantaneous migratory 
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velocity over time. Traces selected from 142 recorded in 4 movies/3 independent 
experiments.
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FIGURE 3. HIV induces an elongated phenotype in infected T cells
a. Analysis of in vitro HIV-infected Tcm in BLT LNs. FTC: Emtricitabine; TDF: Tenofovir. 
b. MP-IVM time-lapse series of uninfected (red) and HIV+ (green) Tcm in a BLT LN. 
Elapsed time in min:sec. c. Mean 2D-track velocities. Red lines and numbers indicate 
medians. d. Correlation of mean cell skeletal length and arrest coefficient of individual cells. 
Dashed lines indicate threshold values based on measurements of uninfected Tcm. Data 
pooled from two independent experiments. e. Production of an R5-tropic, GFP-expressing 
lentiviral vector. f. 48 hours after footpad injection of 1.4 × 105 infectious units, GFP+ cells 
are found in draining LNs. g, h. These cells do not elongate (g) and do not show the 
reduction of cell motility of HIV-infected LN cells (h). Percentages in (g) refer to cells >30 
μm, highlighted by dashed blue box. The red lines and numbers in (h) indicate medians. 
Data are representative of two independent experiments/three mice.
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FIGURE 4. HIV-infected T cells tether to other LN cells and form syncytia through Env, and 
migrate to distant tissues to disseminate infection
a. Intravital micrographs from LNs of BLT mice injected 48 hours earlier with HIV-GFP 
(left) in one, and HIV-GFP ΔEnv (right) into the other footpad. b. Representative traces of 
infected T cells depicting instantaneous cell skeletal length (color-coded) and migratory 
velocity over time. Traces selected from 281 recorded in 14 movies/3 independent 
experiments. c. Mean cell skeletal length and arrest coefficient of individual cells infected 
with HIV-GFP or HIV-GFP ΔEnv. Data are pooled from six and eight recordings, 
respectively, from three independent experiments. d. Cell lengths of HIV-GFP-infected Tcm 
injected into NK cell-depleted, antibody-deficient DHLMP2A mice, and of BLT LN cells 
infected in situ with HIV-GFP D368R or HIV-GFP. e. Recording of LN cells infected with 
HIV-nGFP. Bottom panels indicate border between cytoplasm and nuclei, based on a 80% 
of maximum fluorescence intensity (FI) threshold. f. Cell lengths of mono- and 
multinucleated, HIV-infected cells. g, h. Viremia in NSG BLT mice treated with FTY720 or 
vehicle starting at the day of s.c. HIV-infection via the cheek skin. g. Infection with HIV-
GFP. h. Infection with clone SF162R3. FTY720 treatment was ended at day 56. i. Plasma 
Murooka et al. Page 18
Nature. Author manuscript; available in PMC 2013 April 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
viremia under FTY-treatment started four weeks after in i.p-infection, when virema had 
stabilized. One representative experiment of two is shown.
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